Temporal trends in drug use in one UK region, revealed by chemical group matching

Pharmacoepidemiology and Drug Safety

Volumn 6, Issue 2, 1997, Pages 93-100

  Raffertv, Thérèse ^a   McGavock, Hugh ^a   Wilson Davis, Keith ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

drug use trends; interpretation; regional defined daily doses

Indexed keywords

4 QUINOLONE DERIVATIVE; ANTIDEPRESSANT AGENT; ANTIDIABETIC AGENT; ANTIINFECTIVE AGENT; ANTILIPEMIC AGENT; ANTIULCER AGENT; ANTIVIRUS AGENT; ANXIOLYTIC AGENT; BENZODIAZEPINE DERIVATIVE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BISMUTH CITRATE; CEPHALOSPORIN DERIVATIVE; CROMOGLYCATE DISODIUM; FIBRIC ACID DERIVATIVE; FISH OIL; HISTAMINE H2 RECEPTOR ANTAGONIST; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; HYPNOTIC AGENT; INSULIN; MACROLIDE; MISOPROSTOL; MONOAMINE OXIDASE INHIBITOR; NICOTINIC ACID; OMEPRAZOLE; PROBUCOL; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG;

ARTICLE; DRUG CHOICE; DRUG USE; GEOGRAPHIC DISTRIBUTION; MORBIDITY; PRESCRIPTION; PRIORITY JOURNAL; UNITED KINGDOM;

EID: 0030950039     PISSN: 10538569     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1557(199703)6:2<93::AID-PDS256>3.0.CO;2-B     Document Type: Article

References (12)

1. McGavock, H. Some patterns of prescribing by urban general practitioners. British Medical Journal 1988; 296: 900-902.
2. McGavock, H., Wilson-Davis, K and Niblock, R. Unsuspected patterns of drug utilization revealed by interrogation of a regional drug prescribing database. Pharmacoepidemiology and Drug Safety 1992; 1: 73-80.
3. McGavock, H., Wilson-Davis, K. and Milligan, E. Completing the triangle - relationships between practice demography, general practitioner workload and prescribing. Pharmacoepidemiology and Drug Safety 1993; 2: 28-30.
4. McGavock, H., Wilson-Davis, K. and Rafferty, T. A COMPASS for general practitioner prescribers. Health Trends 1994; 26: 28-30.
5. McGavock, H., Webb, D. H., Johnston, G. D. and Milligan, E. Market penetration by new drugs in one UK region, its implications for general practitioners and administrators. British Medical Journal 1993; 307: 1118-1120.
6. Oydvin, K. and Kristinsson, A. Guidelines for DDD. World Health Organization Collaborating Centre for Drug Statistics Methodology, Oslo, 1991.
7. Oydvin, K. and Alhava, E. Guidelines for ATC Classification. World Health Organization Collaborating Centre for Drug Statistics Methodology, Oslo, 1990.
8. Sinclair, H. K., Bond, C. M. and Taylor, R. J. Hormone replacement therapy: A study of women's knowledge and attitudes. British Journal of General Practice 1993; 43: 365-370.
9. Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease. Lancet 1994; 344: 1383-1389.
10. Superko, H. R. and Krauss, R. M. Coronary artery disease regression. Circulation 1994; 90: 1056-1069.
11. Shepherd, J., Cobbe, S. M., Ford, I., et al. Prevention of coronary heart disease with prevastatin in men with hypercholesterolaemia. New England Journal of Medicine 1995; 333: 1301-1307.
12. McPherson, K. Breast cancer and hormonal supplements in post-menopausal women. British Medical Journal 1995; 311: 699-700.